These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34560087)

  • 41. Ossifying Fibromyxoid Tumor: An Update.
    Bakiratharajan D; Rekhi B
    Arch Pathol Lab Med; 2016 Apr; 140(4):371-5. PubMed ID: 27028395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.
    Velasco IA; Zhang R; Li T; Wang D
    Diagn Pathol; 2018 Mar; 13(1):21. PubMed ID: 29587781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epithelioid hemangioendothelioma with TFE3 translocation in soft tissue:a clinicopathological study].
    Song QY; Zhu XM; Song GX; Li X; Fan QH; Zhang ZH; Gong QX
    Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1151-1156. PubMed ID: 34619869
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.
    Argani P; Antonescu CR; Illei PB; Lui MY; Timmons CF; Newbury R; Reuter VE; Garvin AJ; Perez-Atayde AR; Fletcher JA; Beckwith JB; Bridge JA; Ladanyi M
    Am J Pathol; 2001 Jul; 159(1):179-92. PubMed ID: 11438465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
    Lee SJ; Yang WI; Chung WS; Kim SK
    Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TFE3-rearranged hepatic epithelioid hemangioendothelioma-a case report with immunohistochemical and molecular study.
    Kuo FY; Huang HY; Chen CL; Eng HL; Huang CC
    APMIS; 2017 Sep; 125(9):849-853. PubMed ID: 28585251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ossifying fibromyxoid tumor with atypical histological features: a case report.
    Squillaci S; Tallarigo F; Cazzaniga R; Capitanio A
    Pathologica; 2009 Dec; 101(6):248-52. PubMed ID: 20387713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
    Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
    Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ossifying Fibromyxoid Tumor of the Retromolar Trigone: A Case Report and Systematic Review of the Literature.
    Titsinides S; Nikitakis NG; Tasoulas J; Daskalopoulos A; Goutzanis L; Sklavounou A
    Int J Surg Pathol; 2017 Sep; 25(6):526-532. PubMed ID: 28436288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma.
    Liu N; Guo W; Shi Q; Zhuang W; Pu X; Chen S; Qu F; Xu L; Zhao X; Li X; Zhang G; Guo H; Gan W; Li D
    Sci Rep; 2020 Oct; 10(1):16361. PubMed ID: 33004995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ossifying fibromyxoid tumor: A rare case report with review of literature and its differential diagnosis.
    Dhandapani K; Gandhi J; Gami A
    Indian J Pathol Microbiol; 2024 Jul; 67(3):672-676. PubMed ID: 38391377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ossifying fibromyxoid tumor of soft parts. Report of a rare tumor in Kuwait.
    Al-Brahim N; Dashti MA
    Med Princ Pract; 2008; 17(4):340-2. PubMed ID: 18523405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ossifying fibromyxoid tumor: Fine-needle aspiration cytology findings of a rare soft tissue neoplasm.
    Kumari N; Anthony ML; Durgapal P; Joshi PP; Rajput D; Singh A
    Diagn Cytopathol; 2020 Apr; 48(4):396-400. PubMed ID: 31925994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of known gene rearrangements in endometrial stromal tumors.
    Chiang S; Ali R; Melnyk N; McAlpine JN; Huntsman DG; Gilks CB; Lee CH; Oliva E
    Am J Surg Pathol; 2011 Sep; 35(9):1364-72. PubMed ID: 21836477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consistent rearrangement of chromosomal band 6p21 with generation of fusion genes JAZF1/PHF1 and EPC1/PHF1 in endometrial stromal sarcoma.
    Micci F; Panagopoulos I; Bjerkehagen B; Heim S
    Cancer Res; 2006 Jan; 66(1):107-12. PubMed ID: 16397222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ossifying fibromyxoid tumour of the neck clinically mimicking a primary neoplasm of the thyroid gland.
    Lax SF; Ratschek M; Steindorfer P; Langsteger W; Harms D; Beham A
    Pathol Res Pract; 1995 Feb; 191(1):57-60; discussion 61-3. PubMed ID: 7651934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ossifying fibromyxoid tumor: modified myoepithelial cell tumor? Report of three cases with immunohistochemical and electron microscopic studies.
    Min KW; Seo IS; Pitha J
    Ultrastruct Pathol; 2005; 29(6):535-48. PubMed ID: 16316954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
    Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.